Literature DB >> 10516024

The nucleocapsid domain is responsible for the ability of spleen necrosis virus (SNV) Gag polyprotein to package both SNV and murine leukemia virus RNA.

J L Certo1, T O Kabdulov, M L Paulson, J A Anderson, W S Hu.   

Abstract

Murine leukemia virus (MLV)-based vector RNA can be packaged and propagated by the proteins of spleen necrosis virus (SNV). We recently demonstrated that MLV proteins cannot support the replication of an SNV-based vector; RNA analysis revealed that MLV proteins cannot efficiently package SNV-based vector RNA. The domain in Gag responsible for the specificity of RNA packaging was identified using chimeric gag-pol expression constructs. A competitive packaging system was established by generating a cell line that expresses one viral vector RNA containing the MLV packaging signal (Psi) and another viral vector RNA containing the SNV packaging signal (E). The chimeric gag-pol expression constructs were introduced into the cells, and vector titers as well as the efficiency of RNA packaging were examined. Our data confirm that Gag is solely responsible for the selection of viral RNAs. Furthermore, the nucleocapsid (NC) domain in the SNV Gag is responsible for its ability to interact with both SNV E and MLV Psi. Replacement of the SNV NC with the MLV NC generated a chimeric Gag that could not package SNV RNA but retained its ability to package MLV RNA. A construct expressing SNV gag-MLV pol supported the replication of both MLV and SNV vectors, indicating that the gag and pol gene products from two different viruses can functionally cooperate to perform one cycle of retroviral replication. Viral titer data indicated that SNV cis-acting elements are not ideal substrates for MLV pol gene products since infectious viruses were generated at a lower efficiency. These results indicate that the nonreciprocal recognition between SNV and MLV extends beyond the Gag-RNA interaction and also includes interactions between Pol and other cis-acting elements.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10516024      PMCID: PMC112950     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

1.  Human immunodeficiency virus type 1 nucleocapsid protein specifically stimulates Mg2+-dependent DNA integration in vitro.

Authors:  S Carteau; S C Batson; L Poljak; J F Mouscadet; H de Rocquigny; J L Darlix; B P Roques; E Käs; C Auclair
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Evidence for a unique mechanism of strand transfer from the transactivation response region of HIV-1.

Authors:  J K Kim; C Palaniappan; W Wu; P J Fay; R A Bambara
Journal:  J Biol Chem       Date:  1997-07-04       Impact factor: 5.157

3.  Possible roles of HIV-1 nucleocapsid protein in the specificity of proviral DNA synthesis and in its variability.

Authors:  M Lapadat-Tapolsky; C Gabus; M Rau; J L Darlix
Journal:  J Mol Biol       Date:  1997-05-02       Impact factor: 5.469

4.  Human immunodeficiency virus type 1 nucleocapsid protein promotes efficient strand transfer and specific viral DNA synthesis by inhibiting TAR-dependent self-priming from minus-strand strong-stop DNA.

Authors:  J Guo; L E Henderson; J Bess; B Kane; J G Levin
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

5.  Rous sarcoma virus p19 binds to specific double-stranded regions of viral RNA: effect of p19 on cleavage of viral RNA by RNase III.

Authors:  J P Leis; J McGinnis; R W Green
Journal:  Virology       Date:  1978-01       Impact factor: 3.616

6.  Mutations in the N-terminal domain of human immunodeficiency virus type 1 nucleocapsid protein affect virion core structure and proviral DNA synthesis.

Authors:  L Berthoux; C Péchoux; M Ottmann; G Morel; J L Darlix
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

7.  Improved retroviral packaging lines derived from spleen necrosis virus.

Authors:  I Martinez; R Dornburg
Journal:  Virology       Date:  1995-04-01       Impact factor: 3.616

8.  Correlation of RNA binding affinity of avian oncornavirus p19 proteins with the extent of processing of virus genome RNA in cells.

Authors:  J P Leis; P Scheible; R E Smith
Journal:  J Virol       Date:  1980-09       Impact factor: 5.103

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Characterization of monoclonal antibodies reactive with murine leukemia viruses: use in analysis of strains of friend MCF and Friend ecotropic murine leukemia virus.

Authors:  B Chesebro; W Britt; L Evans; K Wehrly; J Nishio; M Cloyd
Journal:  Virology       Date:  1983-05       Impact factor: 3.616

View more
  14 in total

1.  Functional replacement of nucleocapsid flanking regions by heterologous counterparts with divergent primary sequences: effects of chimeric nucleocapsid on the retroviral replication cycle.

Authors:  William Fu; Wei-Shau Hu
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

Review 2.  The evolution, distribution and diversity of endogenous retroviruses.

Authors:  Robert Gifford; Michael Tristem
Journal:  Virus Genes       Date:  2003-05       Impact factor: 2.332

Review 3.  Structural determinants and mechanism of HIV-1 genome packaging.

Authors:  Kun Lu; Xiao Heng; Michael F Summers
Journal:  J Mol Biol       Date:  2011-07-22       Impact factor: 5.469

4.  Cooperative effect of gag proteins p12 and capsid during early events of murine leukemia virus replication.

Authors:  Sook-Kyung Lee; Kunio Nagashima; Wei-Shau Hu
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

5.  Molecular mechanisms of simian immunodeficiency virus SIV(agm) RNA encapsidation.

Authors:  William Fu; V V S P Prasad; Jianbo Chen; Olga Nikolaitchik; Wei-Shau Hu
Journal:  Virology       Date:  2007-02-26       Impact factor: 3.616

6.  Capsid is an important determinant for functional complementation of murine leukemia virus and spleen necrosis virus Gag proteins.

Authors:  Sook-Kyung Lee; Vitaly Boyko; Wei-Shau Hu
Journal:  Virology       Date:  2006-12-06       Impact factor: 3.616

7.  cis-Acting elements important for retroviral RNA packaging specificity.

Authors:  Benjamin E Beasley; Wei-Shau Hu
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

8.  Involvement of the matrix and nucleocapsid domains of the bovine leukemia virus Gag polyprotein precursor in viral RNA packaging.

Authors:  Huating Wang; Kendra M Norris; Louis M Mansky
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

9.  Functional complementation of nucleocapsid and late domain PTAP mutants of human immunodeficiency virus type 1 during replication.

Authors:  Olga A Nikolaitchik; Robert J Gorelick; Maria G Leavitt; Vinay K Pathak; Wei-Shau Hu
Journal:  Virology       Date:  2008-03-19       Impact factor: 3.616

10.  Chimeras of duck and heron hepatitis B viruses provide evidence for functional interactions between viral components of pregenomic RNA encapsidation.

Authors:  Kristin M Ostrow; Daniel D Loeb
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.